deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02086500

Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial (STAAMP Trial) (STAAMP)

Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial For Trauma Patients At Risk Of Hemorrhage (STAAMP Trial); Phase III Multicenter, Prospective, Randomized, Double Blind, Interventional Trial

Sponsor: Jason Sperry

Conditions Traumatic Hemorrhage
Interventions Saline control Tranexamic Acid
Updated 14 times since 2017 Last updated: Sep 9, 2020 Started: Jul 31, 2015 Primary completion: Nov 30, 2019 Completion: Nov 30, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Traumatic Hemorrhage and is currently completed. Jason Sperry leads this study, which shows 14 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Feb 2018 · 12 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~May 2019 · 6 months · monthly snapshot~May 2019 – ~Oct 2019 · 5 months · monthly snapshot~Oct 2019 – ~Mar 2020 · 5 months · monthly snapshot~Mar 2020 – ~Oct 2020 · 7 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE3

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE3

▶ Show 9 earlier versions

  1. Oct 2020 — Jan 2021 [monthly]

    Completed PHASE3

  2. Mar 2020 — Oct 2020 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

  3. Oct 2019 — Mar 2020 [monthly]

    Recruiting PHASE3

  4. May 2019 — Oct 2019 [monthly]

    Recruiting PHASE3

  5. Nov 2018 — May 2019 [monthly]

    Recruiting PHASE3

  6. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE3

  7. Feb 2018 — Jun 2018 [monthly]

    Recruiting PHASE3

  8. Feb 2017 — Feb 2018 [monthly]

    Recruiting PHASE3

  9. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE3

    First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jason Sperry
  • The University of Texas at San Antonio
  • University of Arizona
  • University of Utah
Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations